COMPANY PROFILE

Relief Cardiovascular

Explore full profile

Innovative closed loop transcatheter implant revolutionizing congestive heart failure treatment

Costa Mesa, United StatesFounded 2022Health Tech & Medtech

Valuation $50–100M Last recorded · 2025

Headcount <100 Current team size

Total funding $10–50M Disclosed equity funding

Unlock exact values

About Relief Cardiovascular

Relief Cardiovascular is pioneering a groundbreaking closed loop transcatheter implant designed to transform the treatment of congestive heart failure. This innovative medical device aims to improve patient outcomes by offering a more efficient and effective solution for managing this chronic condition. Relief Cardiovascular primarily serves healthcare providers and patients suffering from congestive heart failure, operating within the medical device market. The company's business model revolves around the development, manufacturing, and distribution of its proprietary implant, generating revenue through direct sales to hospitals and clinics, as well as partnerships with healthcare organizations.

MoreLess Source: Dealroom company data

At a glance

Status: Operational
Founded: 2022
Headquarters: Costa Mesa, United States
Employees: 18
Open positions: None listed
Dealroom signal: 0.0/100
Industry: Health
Sub-industry: Medical Devices
Sector: Health Tech & Medtech
Business model: Manufacturing
Client focus: b2b
Links: Website LinkedIn

Knowledge graph

Founder mafia, market maps, research and news connected to this company by Dealroom

Funding history

2 recorded events

Company financing events and reported valuations.

Deal type	Date	Amount	Valuation	Investors	Source
SERIES A✓Equity / VC	Jan 2025	$12M	$48M	Advent Life Sciences · Broadview Ventures	↗
OtherOther financing	May 2024	$0	—	MedTech Innovator	↗

Showing the latest 2 of 2 recorded eventsBook a demo for the full funding history →

Growth signals

Relief Cardiovascular website traffic

Latest recorded traffic for Relief Cardiovascular is 1.2K monthly website visits, up 55.8% over the last three months. Relief Cardiovascular's team grew 200% over the past year.

Latest monthly visits1.2K 3-month web change+55.8% 1-year team growth+200%

Monthly website visitsMay 2024–Jul 2026

Explore monthly traffic historyTrack growth over time and compare with peersBook a demo

Summary metrics are public; monthly history is available with a demoCompare with peers →

Similar companies

Closest operating peers by Dealroom taxonomy

Company identity and context are open; selected comparison metrics preview what is available on the platform.

Company	Headquarters	Status	Employees	Total funding	Valuation
RRRush River ResearchA research firm committed to improving medical devices	Minneapolis, United States	Operational	—	$256K	—
OAOrtho AIInnovative platform for screening orthopedic MRI images powered by Artificial Intelligence	Wilmington, United States	Operational
TETestasyNext-generation fertility care platform leveraging the power of AI and optic-less sensor technology	Zurich, Switzerland	Operational
MPMEDU ProtectionProduces sustainable medical equipment, innovating and saving costs while protecting healthcare professionals	Mexico City, Mexico	Operational
CACalyxoAn innovation-driven medical device company focused on improving care for patients with kidney stones, a common and painful condition that consumes vast amounts of healthcare resources today	Pleasanton, United States	Operational
DEDextrainDevelops manual dexterity technology and machine learning analysis to improve neuro-recovery and prediction, enhancing daily life of millions of individuals	Igny, France	Operational
RHReti HealthAI-powered cardiovascular screening from retinal images.	London, United Kingdom	Operational
OROrbusNeichA global pioneer in the development of life-changing vascular solutions	Sha Tin District, Hong Kong	Operational